We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-16.7%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$5.13B
(-23%)
Cap. Flow
-$794M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
494
New
36
Increased
156
Reduced
156
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$108M |
| 2 |
Visa
V
|
+$102M |
| 3 |
Mercado Libre
MELI
|
+$73M |
| 4 |
Enphase Energy
ENPH
|
+$58.6M |
| 5 |
Snowflake
SNOW
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$147M |
| 2 |
Y
Alleghany Corp
Y
|
+$137M |
| 3 |
Applied Materials
AMAT
|
+$116M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$115M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Industrials | 25.1% |
| 3 | Healthcare | 17.44% |
| 4 | Financials | 14.96% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Zai Lab
ZLAB
$2.79B
| $4.99M | 0.03% |
143,997
+11,615
| +9% | +$410K |
|
|
CTLT
227
DELISTED
CATALENT, INC.
CTLT
| $4.91M | 0.03% |
45,779
-2,748
| -6% | -$280K |
|
228
Natera
NTRA
$50.2B
| $4.91M | 0.03% |
138,498
+8,666
| +7% | +$321K |
|
|
VTNR
229
DELISTED
Vertex Energy, Inc
VTNR
| $4.72M | 0.03% |
+448,975
| New | +$5.32M |
|
230
PayPal
PYPL
$46B
| $4.7M | 0.03% |
67,293
-147,808
| -69% | -$12.8M |
|
231
Ares Capital
ARCC
$13.9B
| $4.62M | 0.03% |
257,893
-4,860
| -2% | -$95.8K |
|
232
Deere & Co
DE
$185B
| $4.48M | 0.03% |
14,956
+7,397
| +98% | +$2.72M |
|
233
Impinj
PI
$5.23B
| $4.35M | 0.03% |
74,137
-12,803
| -15% | -$643K |
|
234
Rockwell Automation
ROK
$46.3B
| $4M | 0.02% |
20,088
-37,308
| -65% | -$8.43M |
|
235
Labcorp
LH
$25.9B
| $4M | 0.02% |
19,872
-12,691
| -39% | -$2.71M |
|
236
Golub Capital BDC
GBDC
$3.24B
| $3.76M | 0.02% |
289,880
-4,550
| -2% | -$65.1K |
|
237
Teleflex
TFX
$5.43B
| $3.62M | 0.02% |
14,718
| – | – |
|
238
Flywire
FLYW
$2.18B
| $3.46M | 0.02% |
+196,001
| New | +$4.55M |
|
239
Logitech
LOGI
$14.5B
| $3.27M | 0.02% |
62,576
-36,046
| -37% | -$2.22M |
|
|
QTNT
240
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $3.21M | 0.02% |
334,416
+103,125
| +45% | +$2.2M |
|
|
INFI
241
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $3.16M | 0.02% |
5,000,000
| – | – |
|
|
LTHM
242
DELISTED
Livent Corporation
LTHM
| $3.05M | 0.02% |
134,477
+87,763
| +188% | +$2.26M |
|
243
Plug Power
PLUG
$2.88B
| $2.99M | 0.02% |
180,331
-56,815
| -24% | -$1.13M |
|
|
NIU
244
Niu Technologies
NIU
$158M
| $2.98M | 0.02% |
346,169
+164,140
| +90% | +$1.39M |
|
|
NVRO
245
DELISTED
NEVRO CORP.
NVRO
| $2.9M | 0.02% |
66,043
+19,396
| +42% | +$1.07M |
|
|
AMED
246
DELISTED
Amedisys
AMED
| $2.69M | 0.02% |
25,604
-56,776
| -69% | -$7.25M |
|
247
Cognex
CGNX
$9.85B
| $2.69M | 0.02% |
63,173
+1,467
| +2% | +$82.2K |
|
248
Qiagen
QGEN
$8.89B
| $2.64M | 0.02% |
43,873
| – | – |
|
249
Vertiv
VRT
$91.5B
| $2.5M | 0.01% |
304,035
+36,521
| +14% | +$413K |
|
250
Sociedad Química y Minera de Chile
SQM
$19.8B
| $2.46M | 0.01% |
29,456
-7,011
| -19% | -$617K |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, Polar Capital Holdings held 494 positions worth $17B, down 23% from $22.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Polar Capital Holdings withdrew a net $794M in Q2 2022, closing 61 positions and reducing 156 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Polar Capital Holdings opened a new position in Sanofi worth $36.3M.
- Polar Capital Holdings's largest Q2 2022 buy was Sanofi: 725,000 shares worth $36.3M.
- Polar Capital Holdings added most to Salesforce in Q2 2022, an estimated $108M increase.
- Polar Capital Holdings's biggest Q2 2022 reduction was Applied Materials, cutting an estimated $116M.
- Polar Capital Holdings fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $147M.
- Polar Capital Holdings's ten largest holdings make up 43% of its $17B portfolio in Q2 2022.
- Polar Capital Holdings opened 36 new positions and closed 61 in Q2 2022.
- Polar Capital Holdings's portfolio value fell 23% quarter-over-quarter to $17B.
Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.